Medicine:NephroCheck
From HandWiki
NephroCheck is a test that tries to determine the risk of some who is seriously sick developing acute kidney injury.[1] Whether or not the test improves outcomes, however, is unclear as of 2016.[2] NephroCheck tests for the presence of insulin-like growth-factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases (TIMP-2) in the urine, which are associated with acute kidney injury.[1] The laboratory test was developed by Astute Medical, in San Diego, California.[1]
References
- ↑ 1.0 1.1 1.2 FDA. "FDA allows marketing of the first test to assess risk of developing acute kidney injury.". FDA. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm412910.htm. Retrieved 2014-09-05.
- ↑ Lameire, N; Vanmassenhove, J; Van Biesen, W; Vanholder, R (June 2016). "The cell cycle biomarkers: promising research, but do not oversell them.". Clinical Kidney Journal 9 (3): 353–8. doi:10.1093/ckj/sfw033. PMID 27274818.
 |  |
